The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane‑ induced sensory neuropathy: A randomized clinical trial

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AVAN RAZIEH; JANBABAEI GHASEM; Hendouei Narjes; ALIPOUR ABBAS; BORHANI SAMANEH; TABRIZI NASIM; SALEHIFAR EBRAHIM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS) Year:2018 | Volume:23 | Issue:6 Page(s): 0-0

Download Full-Text

View:

190

Download:

181

Cites:

Information Journal Paper

Title

The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane‑ induced sensory neuropathy: A randomized clinical trial

Author(s)

Keywords

Duloxetine

neuropathy

pregabalin

quality of life

taxanes

Abstract

Background: The primary side effect of adjuvant chemotherapy with taxanes is the taxane‑ induced peripheral neuropathy (TIPN), which may have substantial negative impacts on patients’ quality of life (QOL). We investigated the effect of pregabalin and Duloxetine on QOL of breast cancer patients who experienced TIPN. Materials and Methods: This was a randomized, double‑ blind clinical trial conducted at a chemotherapy center of Mazandaran University of Medical Sciences, Sari, Iran. Breast cancer patients 18 or more years old were included if they received paclitaxel or docetaxel and experienced neuropathy grade one or higher; and neuropathic pain score of four or more. Patients were treated with pregabalin or Duloxetine until 6 weeks. Assessment of sensory neuropathy and QOL was performed at baseline, and 6 weeks after the initiation of the treatment. Results: At baseline, the mean score of global health status/QOL scale for pregabalin and Duloxetine groups were 61 (standard deviation [SD]; 5. 11) and 60. 28 (SD; 5. 44), respectively (P = 0. 54). After 6 weeks, both interventions were associated with improvement of global QOL compared to baseline. The global health status/QOL score was not different between two groups after 6 weeks. While the emotional functioning was improved more favorably with Duloxetine (P < 0. 001); pregabalin was associated with more improvement in insomnia and pain scores (P = 0. 05 and P < 0. 001, respectively). Conclusion: pregabalin as well as Duloxetine improve the global QOL of breast cancer patients with TIPN. Different effects of treatments on subscale of QLQ‑ C30 could help clinicians to select the appropriate agent individually.

Cites

No record.

References

No record.

Cite

APA: Copy

AVAN, RAZIEH, JANBABAEI, GHASEM, Hendouei, Narjes, ALIPOUR, ABBAS, BORHANI, SAMANEH, TABRIZI, NASIM, & SALEHIFAR, EBRAHIM. (2018). The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane‑ induced sensory neuropathy: A randomized clinical trial. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 23(6), 0-0. SID. https://sid.ir/paper/734807/en

Vancouver: Copy

AVAN RAZIEH, JANBABAEI GHASEM, Hendouei Narjes, ALIPOUR ABBAS, BORHANI SAMANEH, TABRIZI NASIM, SALEHIFAR EBRAHIM. The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane‑ induced sensory neuropathy: A randomized clinical trial. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2018;23(6):0-0. Available from: https://sid.ir/paper/734807/en

IEEE: Copy

RAZIEH AVAN, GHASEM JANBABAEI, Narjes Hendouei, ABBAS ALIPOUR, SAMANEH BORHANI, NASIM TABRIZI, and EBRAHIM SALEHIFAR, “The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane‑ induced sensory neuropathy: A randomized clinical trial,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 23, no. 6, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/734807/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops